Kota S, Kota S
bioRxiv. 2025; .
PMID: 40060432
PMC: 11888273.
DOI: 10.1101/2025.02.25.640014.
Miao X, Wang S, Wang Y, Cheng S, Wang X, Chen Y
BMC Genomics. 2024; 25(1):1167.
PMID: 39623364
PMC: 11610100.
DOI: 10.1186/s12864-024-10992-x.
Li M, Feng J, Zhao K, Huang T, Zhang B, Yang Y
Biomolecules. 2024; 14(11).
PMID: 39595554
PMC: 11591952.
DOI: 10.3390/biom14111377.
Poltronieri P
Explor Target Antitumor Ther. 2024; 5(4):841-876.
PMID: 39280246
PMC: 11390297.
DOI: 10.37349/etat.2024.00252.
Malla S, Kumari K, Garcia-Prieto C, Caroli J, Nordin A, Phan T
Nat Commun. 2024; 15(1):7758.
PMID: 39237615
PMC: 11377572.
DOI: 10.1038/s41467-024-51966-7.
Epigenetic regulation of NKG2D ligand and the rise of NK cell-based immunotherapy for cancer treatment.
Kumar R, Gupta R
Front Oncol. 2024; 14:1456631.
PMID: 39161385
PMC: 11330816.
DOI: 10.3389/fonc.2024.1456631.
The Molecular and Biological Function of MEF2D in Leukemia.
Zhang P, Lu R
Adv Exp Med Biol. 2024; 1459:379-403.
PMID: 39017853
DOI: 10.1007/978-3-031-62731-6_17.
KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.
Chen Y, Johnson J, Jayamohan S, He Y, Venkata P, Jamwal D
Mol Carcinog. 2024; 63(10):2026-2039.
PMID: 38990091
PMC: 11421967.
DOI: 10.1002/mc.23792.
The role of HOTAIR in the modulation of resistance to anticancer therapy.
Cantile M, Belli V, Scognamiglio G, Martorana A, De Pietro G, Tracey M
Front Mol Biosci. 2024; 11:1414651.
PMID: 38887279
PMC: 11181001.
DOI: 10.3389/fmolb.2024.1414651.
Protein degradation of Lsd1 is mediated by Bre1 yet opposed by during fly follicle development.
Lin C, Ting R, Ou Y, Shao T, Lee M
iScience. 2024; 27(5):109683.
PMID: 38655201
PMC: 11035368.
DOI: 10.1016/j.isci.2024.109683.
Strategies that regulate LSD1 for novel therapeutics.
Li M, Dai M, Cheng B, Li S, Guo E, Fu J
Acta Pharm Sin B. 2024; 14(4):1494-1507.
PMID: 38572094
PMC: 10985039.
DOI: 10.1016/j.apsb.2024.01.005.
Kdm1a safeguards the topological boundaries of PRC2-repressed genes and prevents aging-related euchromatinization in neurons.
Del Blanco B, Ninerola S, Martin-Gonzalez A, Paraiso-Luna J, Kim M, Munoz-Viana R
Nat Commun. 2024; 15(1):1781.
PMID: 38453932
PMC: 10920760.
DOI: 10.1038/s41467-024-45773-3.
Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study.
Johnson J, Alejo S, Jayamohan S, Sareddy G
Expert Opin Ther Targets. 2023; 27(12):1177-1188.
PMID: 37997756
PMC: 10872912.
DOI: 10.1080/14728222.2023.2288277.
KDM3A and KDM3B Maintain Naïve Pluripotency Through the Regulation of Alternative Splicing.
Dillingham C, Cormaty H, Morgan E, Tak A, Esgdaille D, Boutz P
bioRxiv. 2023; .
PMID: 37398291
PMC: 10312572.
DOI: 10.1101/2023.05.31.543088.
Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation.
Antona A, Leo G, Favero F, Varalda M, Venetucci J, Faletti S
Cell Death Discov. 2023; 9(1):201.
PMID: 37385999
PMC: 10310788.
DOI: 10.1038/s41420-023-01502-1.
Roles of long non-coding RNAs in plant immunity.
Huang J, Zhou W, Zhang X, Li Y
PLoS Pathog. 2023; 19(5):e1011340.
PMID: 37167200
PMC: 10174565.
DOI: 10.1371/journal.ppat.1011340.
Genetic Variants of HOTAIR Associated with Colorectal Cancer: A Case-Control Study in the Saudi Population.
Alzeer H, P Shaik J, Reddy Parine N, Alanazi M, Alamri A, Bhat R
Genes (Basel). 2023; 14(3).
PMID: 36980864
PMC: 10047939.
DOI: 10.3390/genes14030592.
Viscosalactone B, a natural LSD1 inhibitor, inhibits proliferation in vitro and in vivo against prostate cancer cells.
Yan G, Zhang H, Li Y, Miao G, Liu X, Lv Q
Invest New Drugs. 2023; 41(1):134-141.
PMID: 36692618
DOI: 10.1007/s10637-023-01330-1.
Regulation of EWSR1-FLI1 Function by Post-Transcriptional and Post-Translational Modifications.
Yu L, Davis I, Liu P
Cancers (Basel). 2023; 15(2).
PMID: 36672331
PMC: 9857208.
DOI: 10.3390/cancers15020382.
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma.
Alejo S, Palacios B, Pitta Venkata P, He Y, Li W, Johnson J
Neuro Oncol. 2023; 25(7):1249-1261.
PMID: 36652263
PMC: 10326496.
DOI: 10.1093/neuonc/noad018.